August 3, 2007 – Novation, a healthcare contracting and services company of VHA Inc. and the University HealthSystem Consortium (UHC), awarded ev3 Inc. three, three-year contracts beginning Oct.
August 3, 2007 - CryoCor Inc., a medical device company focused on the treatment of cardiac arrhythmias, announced today that the FDA has granted pre-market approval (PMA) for its Cardiac Cryoablation System for the treatment of right atrial flutter, enabling CryoCor to target over 200,000 U.S. patients treating flutter with cryoablation annually.
August, 3, 2007 - In patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C), there is a high rate of recurrence following radiofrequency (RF) catheter ablation following electrophysiologic mapping, researchers report in the July 31st issue of the Journal of the American College of Cardiology.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
August 3, 2007 - Volcano Corp. announced it has received approval by regulatory authorities in Japan to market the ...
August 3, 2007 - World Heart Corp. (WorldHeart), a developer of mechanical circulatory support systems, recently ...
August 2, 2007 — Siemens Medical Solutions Diagnostics announced the availability of the ADVIA 1800 chemistry system ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
August 1, 2007 - Positron Corp. announced that a recent study by The State University of New York at Buffalo reveals that Positron Emission Tomography (PET) scanning when used as the first tool to diagnose heart-vessel blockages, is more accurate, less invasive and cost effective than SPECT imaging.
August 1, 2007 - AGA Medical Corp. (AGA), owner of a European patent (EP 0 808 138) for intravascular occlusion devices ...
August 1, 2007 - SonoSite Inc., a developer of portable ultrasound, announced it has acquired LumenVu Inc., a company ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
August 1, 2007 - BioControl Medical announced that cardiologists at University Hospital Mannheim in Germany and at Ospedali Riuniti di Bergamo in Italy have successfully implanted the CardioFit device in the first patients to be enrolled at those sites in BioControl’s international, multi-center clinical study of the CardioFit system, marking an important step for the treatment of advanced conge
July 31, 2007 - Implantable defibrillators can reduce the risk of sudden death in high-risk patients with hypertrophic cardiomyopathy, according to a new study conducted at the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute Foundation and published in the July 25 issue of the Journal of the American Medical Association.
July 31, 2007 — eCardio Diagnostics announced it is expanding its facilities with a new state-of-the-art diagnostic ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 31, 2007 - GlaxoSmithKline announced the recommendation of an FDA advisory committee to support Avandia’s (rosiglitazone maleate), an oral anti-diabetic medicine, continued availability to patients in the U.S., information which the FDA will consider its final decision-making process.
July 30, 2007 - Outcome Sciences Inc., a medical software developer, announced that it has added a Continuity of Care Records (CCR) functionality to the its Get With The Guidelines (GWTG) Patient Management Tool (PMT), a data collection and reporting platform for patients with coronary artery disease (CAD), heart failure and stroke, as part of a joint effort with the American Heart Association to
July 30, 2007 – The FDA gave Cook Medical, a developer of IVC filters, clearance for a permanent indication for its newest vena cava filter, Celect, which is designed to offer physicians a tool for minimizing the risk of blood clots and pulmonary embolism in their patients.